BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ueda M, Terai Y, Kumagai K, Ueki K, Kanemura M, Ueki M. Correlation between thymidine phosphorylase expression and invasion phenotype in cervical carcinoma cells. Int J Cancer 2001;91:778-82. [PMID: 11275979 DOI: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1133>3.0.co;2-s] [Cited by in Crossref: 26] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Warfield BM, Reigan P. Multifunctional role of thymidine phosphorylase in cancer. Trends in Cancer 2022. [DOI: 10.1016/j.trecan.2022.01.018] [Reference Citation Analysis]
2 Bisht N, Bhatnagar S, Sundaram V, Singh S, Lohia N. A Comparative Study of Two Protocols of Concurrent Chemotherapy with External Beam Radiotherapy in Treatment of Locally Advanced Cervical Cancer: Cisplatin Versus Cisplatin Plus Capecitabine Combination. Indian J Gynecol Oncolog 2021;19. [DOI: 10.1007/s40944-021-00501-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Du HT, Du LL, Tang XL, Ge HY, Liu P. Blockade of MMP-2 and MMP-9 inhibits corneal lymphangiogenesis. Graefes Arch Clin Exp Ophthalmol 2017;255:1573-9. [PMID: 28669039 DOI: 10.1007/s00417-017-3651-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
4 Dueñas-González A, Cetina L, Coronel J, Martínez-Baños D. Pharmacotherapy options for locally advanced and advanced cervical cancer. Drugs 2010;70:403-32. [PMID: 20205484 DOI: 10.2165/11534370-000000000-00000] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
5 Bronckaers A, Gago F, Balzarini J, Liekens S. The dual role of thymidine phosphorylase in cancer development and chemotherapy. Med Res Rev. 2009;29:903-953. [PMID: 19434693 DOI: 10.1002/med.20159] [Cited by in Crossref: 128] [Cited by in F6Publishing: 120] [Article Influence: 10.7] [Reference Citation Analysis]
6 Kobayashi Y, Wada Y, Ohara T, Okuda Y, Suzuki N, Hasegawa K, Kiguchi K, Ishizuka B. Enzymatic activities of uridine and thymidine phosphorylase in normal and cancerous uterine cervical tissues. Hum Cell. 2007;20:107-110. [PMID: 17949350 DOI: 10.1111/j.1749-0774.2007.00036.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
7 Candelaria M, Garcia-Arias A, Cetina L, Dueñas-Gonzalez A. Radiosensitizers in cervical cancer. Cisplatin and beyond. Radiat Oncol 2006;1:15. [PMID: 16722549 DOI: 10.1186/1748-717X-1-15] [Cited by in Crossref: 50] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
8 Kabuubi P, Loncaster JA, Davidson SE, Hunter RD, Kobylecki C, Stratford IJ, West CM. No relationship between thymidine phosphorylase (TP, PD-ECGF) expression and hypoxia in carcinoma of the cervix. Br J Cancer 2006;94:115-20. [PMID: 16317434 DOI: 10.1038/sj.bjc.6602882] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
9 Zhou J, Xiao YS, Tang ZY, Fan J, Wu ZQ, Zhao Y, Xue Q, Shen ZZ, Liu YK, Ye SL. Transfection of thymidine phosphorylase cDNA to human hepatocellular carcinoma cells enhances sensitivity to fluoropyrimidine but augments endothelial cell migration. J Cancer Res Clin Oncol 2005;131:547-51. [PMID: 15864645 DOI: 10.1007/s00432-005-0669-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]